NDC 16729-366-45 - OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-366
- Requested NDC
- 16729-366-45
- Package NDCs from labels
- 16729-366-10, 16729-366-15, 16729-366-16, 16729-366-17, 16729-366-45, 16729-366-46
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2025-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LACTOSE MONOHYDRATE - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2025-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE - A-S Medication Solutions | A-S Medication Solutions | 2023-07-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-366-10 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 16729-366-15 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 16729-366-16 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 7 | |
| 16729-366-17 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 7 | |
| 16729-366-45 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 7 | |
| 16729-366-46 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 100 in 1 CARTON | TABLET, FILM COATED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-366-10 | EA - Each | 16729-366 | 39fc2de8-f862-4a2d-a12c-bfab23d6c60e | 1 | 2020-09-14 |
| 16729-366-15 | EA - Each | 16729-366 | 3400d9ab-caf6-4425-9c27-24a6d36b5abb | 1 | 2020-09-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER 33N | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | ab1c8e9e-fd8f-473e-8930-625706e8e9d6 | 2025-12-09 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER 29W | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 17073264-ec02-4801-841d-86778debd8c4 | 2025-12-09 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER 41N | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | caee5c88-1907-41c1-987e-5bc544267dca | 2025-12-09 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER 33W | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 973b70f1-ee59-4dd9-aca3-432d721204ab | 2025-12-09 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER 27W | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 208fe03e-384b-4599-a4d0-a553fba306da | 2025-12-09 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER 35N | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 279258dd-b3fa-47be-8540-66bd9c879fc5 | 2025-12-09 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER 47N | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | c2ad2a5e-f8fe-41b3-8b0f-9981c337ec5c | 2025-12-09 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER 31N | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 4206b607-5c26-4c9d-ade7-58c9740cdbe8 | 2025-12-09 | Warnings | 15FIX9V2JP |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Lifestar Pharma LLC | 9771066e-c05d-6a93-e053-2995a90a7e87 | 2025-12-09 | Boxed warning, Warnings, Adverse reactions | 403855 403853 403854 0J48LPH2TH 6M97XTV3HD |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | Lifestar Pharma LLC | a337a621-bf57-4aa4-8224-4356fa2cdbc4 | 2025-12-09 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Non-tinted Physical Block Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Tucson Acne Clinic | 30dd2f6b-5dcc-b081-e063-6394a90ae5f1 | 2025-12-09 | Warnings | 15FIX9V2JP |
| Tinted Physical Block Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Tucson Acne Clinic | 30dc6e23-ecca-ed0b-e063-6294a90a7951 | 2025-12-09 | Warnings | 15FIX9V2JP |
| Tinted Physical Block Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Tucson Acne Clinic | 30ddc3d7-76df-3344-e063-6294a90a65ae | 2025-12-09 | Warnings | 15FIX9V2JP |
| Tinted Physical Block Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Tucson Acne Clinic | 30ddf80c-8496-0f47-e063-6394a90afc18 | 2025-12-09 | Warnings | 15FIX9V2JP |
| Advanced Lip Guard | TITANIUM DIOXIDE, ZINC OXIDE | ADVANCED DERMATOLOGY | 32e66ff3-ae1a-4a2a-e063-6294a90a7963 | 2025-12-09 | 15FIX9V2JP | |
| Original Tint | TITANIUM DIOXIDE, ZINC OXIDE | L.S. MOORE LLC | 37f1e019-32c4-b733-e063-6394a90aca28 | 2025-12-09 | 15FIX9V2JP | |
| Original Tint | TITANIUM DIOXIDE, ZINC OXIDE | L.S. MOORE LLC | 37f2e363-e85f-f601-e063-6294a90ab120 | 2025-12-09 | 15FIX9V2JP | |
| Original Tint | TITANIUM DIOXIDE, ZINC OXIDE | L MOORE AESTHETICS | 37f1ac8c-3bfb-10da-e063-6294a90a8ca8 | 2025-12-09 | 15FIX9V2JP | |
| Mineral Sunscreen Dry Touch NT | TITANIUM DIOXIDE, ZINC OXIDE | Cutis Wellness Dermatology And Dermatopathology PLLC | 334ffc49-3196-0995-e063-6394a90ad559 | 2025-12-09 | 15FIX9V2JP | |
| Foam Weightless Sunscreen Non-Tinted Drytouch NT | TITANIUM DIOXIDE, ZINC OXIDE | Cutis Wellness Dermatology And Dermatopathology PLLC | 335ec22c-6a9a-c4d1-e063-6394a90ac0b0 | 2025-12-09 | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.